While the FDA continues to issue 483s to 503B facilities, hospital pharmacies report a significant reduction over the last year in quality problems such as mislabeled or wrong volume products received from their vendors. Just 9% of pharmacies have experienced a recent quality problem with their vendor. While most hospital pharmacies are confident in the corrective action plans their vendor has implemented in response to any quality problems, a notable 22% are not satisfied with their vendor’s plan.
Over the past year, CAPS, Nephron, QuVa, and SCA Pharma have become the leading outsourced compounding vendors.
Like what you've read? Please log in or create a free account to enjoy more of what www.pppmag.com has to offer.